Sirtuin-Activating Peptides
Overview
Sirtuin-activating peptides represent a class of investigational compounds designed to enhance the enzymatic activity of sirtuins, a family of NAD-dependent deacetylases implicated in longevity and metabolic regulation. These peptides aim to mimic or potentiate the effects of caloric restriction by modulating histone deacetylation, mitochondrial biogenesis, and stress resistance pathways.
Mechanism of Action
While small molecule sirtuin activators such as resveratrol analogues have received more research attention, peptide-based approaches remain in early discovery phases. The therapeutic rationale centers on reproducing the lifespan-extending effects of sirtuin overexpression observed in lower organisms..
Research Summary & Key Findings
Most evidence for sirtuin activation and longevity derives from studies using genetic manipulation or small molecule activators in yeast, worms, and mice rather than peptide therapeutics. Peptide-based sirtuin modulators have been characterized in vitro and in preliminary rodent studies, but no clinical trials have evaluated safety or efficacy in humans. The translation of sirtuin biology to human aging interventions remains an active area of investigation without conclusive clinical proof of concept.
Clinical Status
Sirtuin-Activating Peptides is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
Administration Routes
Related Peptides in Longevity
Epithalon (Epitalon)
Research PhaseA synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin peptide produced by the pineal gland. Epitha...
View detailsMOTS-c
Research PhaseA mitochondrial-derived peptide encoded by the 12S rRNA gene of mitochondrial DNA. MOTS-c is a 16-amino acid peptide tha...
View detailsHumanin
Research PhaseA 24-amino acid mitochondrial-derived peptide encoded within the 16S rRNA region of mitochondrial DNA. Humanin exerts cy...
View detailsNAD+ Precursors (NMN)
In Clinical TrialsNicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coen...
View detailsFind a Provider
Find a verified provider who offers Sirtuin-Activating Peptides therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Sirtuin-Activating Peptides.
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.